Log in to save to my catalogue

Neutralizing antibody activity in convalescent sera from infection in humans with SARS-CoV-2 and var...

Neutralizing antibody activity in convalescent sera from infection in humans with SARS-CoV-2 and var...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8556155

Neutralizing antibody activity in convalescent sera from infection in humans with SARS-CoV-2 and variants of concern

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

COVID-19 vaccine design and vaccination rollout need to take into account a detailed understanding of antibody durability and cross-neutralizing potential against SARS-CoV-2 and emerging variants of concern (VOCs). Analyses of convalescent sera provide unique insights into antibody longevity and cross-neutralizing activity induced by variant spike...

Alternative Titles

Full title

Neutralizing antibody activity in convalescent sera from infection in humans with SARS-CoV-2 and variants of concern

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8556155

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8556155

Other Identifiers

ISSN

2058-5276

E-ISSN

2058-5276

DOI

10.1038/s41564-021-00974-0

How to access this item